PIN1 and breast carcinoma: As a result of enhancing cellular uptake of ATO, combined treatment of ATO with ATRA synergistically reduces PIN1 expression, suppresses multiple PIN1-regulated oncogenic pathways, and inhibits breast cancer cell proliferation in vitro and in vivo as compared with ATO or ATRA alone (Kozono et al., 2018).